TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

$50 Million

Synlogic Inc.

At-the-market Offering

Synlogic Inc is a biopharmaceutical company focused on advancing the drug discovery and development platform for Synthetic Biotic medicines, which are designed using synthetic biology to genetically reprogram beneficial microbes to treat metabolic and inflammatory diseases and cancer.